Andrew Tebben
About Andrew Tebben
Andrew Tebben is the Director of Research Project Management at Bristol Myers Squibb in Princeton, New Jersey, with over 20 years of experience in the pharmaceutical industry.
Current Role at Bristol Myers Squibb
Andrew Tebben currently serves as the Director of Research Project Management at Bristol Myers Squibb in Princeton, New Jersey. He began this role in September 2021. With more than 20 years of experience in the pharmaceutical industry, he brings extensive expertise to his position, focusing on overseeing and directing various research projects within the company.
Previous Roles at Bristol Myers Squibb
Before his current role, Andrew Tebben held several positions at Bristol Myers Squibb. He was the Associate Director of Research Project Management from 2019 to 2021 in Lawrenceville, New Jersey. Prior to that, he served as Principal Scientist and Computational Chemistry Group Leader from 2003 to 2019. His long tenure at the company reflects his deep commitment and valuable contributions to its research and development efforts.
Past Experience at Merck and DuPont Pharmaceuticals
Andrew Tebben began his pharmaceutical career at Merck, where he worked as a Research Scientist from 1992 to 1999. He later joined DuPont Pharmaceuticals as a Senior Research Investigator II, holding this position from 1999 to 2003. His experience at these top pharmaceutical companies laid a strong foundation for his expertise in research and project management.
Educational Background in Chemistry
Andrew Tebben studied Chemistry at The Ohio State University, where he earned a Bachelor of Science degree from 1987 to 1991. He then pursued further studies at Villanova University, obtaining a Master of Science degree in Chemistry from 1992 to 1995. His academic background provided him with a robust foundation in chemistry that supports his extensive research work in the pharmaceutical industry.
Expertise in GPCR Modeling, Structure Based Design, and Kinase Modeling
With over two decades of experience in the pharmaceutical industry, Andrew Tebben has developed specialized expertise in GPCR Modeling, Structure Based Design, and Kinase Modeling. These areas are critical to the development of new therapeutic agents and underscore his contributions to advancing pharmaceutical research and development.